NeuroSense Therapeutics Ltd. Other Significant Noncash Transaction, Value of Consideration Given
NeuroSense Therapeutics Ltd. (NRSN) reported Other Significant Noncash Transaction, Value of Consideration Given of $3 for the 12-month period ending 2021-12-31, per its 6-K filed 2024-06-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2024-06-17
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 12 month |
|---|---|
| 2021-12-31 | $3.00 6-K · filed 2024-06-17 |